Lorvotuzumab Mertansine
Lorvotuzumab Mertansine Basic information
- Product Name:
- Lorvotuzumab Mertansine
- Synonyms:
-
- Lorvotuzumab Mertansine
- Research Grade Lorvotuzumab (DHC98501)
- Lorvotuzumab mertansine (ADC)
- Research Grade Lorvotuzumab
- CAS:
- 1008106-64-6
- MW:
- 0
- Mol File:
- Mol File
More
Less
Lorvotuzumab Mertansine Usage And Synthesis
Uses
Lorvotuzumab mertansine is an ADC consisting of a humanized N901 monoclonal antibody against CD56 bound to maytansinoid DM1 via a stable disulfide linker. Lorvotuzumab mertansine has antitumor activity[1].
in vivo
Lorvotuzumab mertansine (3-51 mg/kg, i.v., once) has potent anti-tumour activity in CB.17 SCID mice with SW2 SCLC xenograft tumor[1].
| Animal Model: | SW2 SCLC xenograft tumor CB.17 SCID mice |
| Dosage: | 3、17 and 51 mg/kg |
| Administration: | i.v., once |
| Result: | Showed high anti-tumor activity at a dose of 17 mg/kg with half of the animals being tumor free and complete tumor regression at a dose of 51 mg/kg. |
References
[1] Kathleen R Whiteman, et al. Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models. MAbs. 2014 Mar-Apr;6(2):556-66. DOI:10.4161/mabs.27756
Lorvotuzumab MertansineSupplier
Guangzhou Hongyuan Chemical Co.,Ltd
- Tel
- 15817493340
- 981810490@qq.com
Wuhan Chemstan Biotechnology Co., Ltd.
- Tel
- 027-65317797 15926423062
- 422450190@qq.com
Biolab Reagents
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com
Wuhan Jingkangen Biomedical Technology Co., Ltd
- Tel
- 13720134139 086-15871494362 13720134139
- orders@jknbiochem.com
Shanghai Yifei Biotechnology Co. , Ltd.
- Tel
- 021-65675885 18964387627
- customer_service@efebio.com